Lymphocyte depletion in Hodgkin lymphoma is characterized by a reduction in lymphocytes in the lymph nodes and solid organs. This condition is clinically significant as it indicates advanced disease and can lead to immunosuppression, increasing the risk of infections. Accurate coding with ICD-10 Code C81.39 is essential for proper diagnosis, documentation, medical billing, and public health reporting.
ICD-10 Code C81.39 represents lymphocyte depletion associated with Hodgkin lymphoma affecting extranodal sites and solid organs. This code is used when documenting cases where lymphocyte levels are significantly reduced, indicating a more severe form of the disease. It is crucial for accurate clinical documentation and billing, particularly in oncology settings.
Lymphocyte depletion in Hodgkin lymphoma is often a result of the disease's progression, leading to significant immunocompromise. This condition necessitates prompt medical intervention to manage symptoms and prevent complications. Understanding its clinical features is vital for effective treatment planning.
ICD-10 Code C81.39 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation of the patient's condition.
In SOAP notes, ICD-10 Code C81.39 connects subjective patient reports and objective clinical findings to a formal diagnosis of lymphocyte depletion in Hodgkin lymphoma. This linkage is essential for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of lymphocyte depletion in Hodgkin lymphoma requires a multifaceted approach, often necessitating hospitalization for intensive treatment.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C81.39 is critical in billing for hospitalizations and treatments related to lymphocyte depletion in Hodgkin lymphoma.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 36415 | Collection of venous blood by venipuncture. |
| 85025 | Complete blood count (CBC) with automated differential. |
| 99223 | Initial hospital care, typically 70 minutes or more. |
Common Questions About Using ICD-10 Code C81.39 for Lymphocy deplet Hdgkn lymph, extrnod & solid org site
What are the common symptoms of lymphocyte depletion in Hodgkin lymphoma?
Common symptoms include fatigue, recurrent infections, unexplained weight loss, and night sweats. These symptoms indicate the severity of the disease and the need for immediate medical attention.
How is ICD-10 Code C81.39 used in billing?
ICD-10 Code C81.39 is used in billing to document lymphocyte depletion due to Hodgkin lymphoma. Accurate coding ensures proper reimbursement and compliance with healthcare regulations.
What treatments are available for lymphocyte depletion in Hodgkin lymphoma?
Treatment typically includes chemotherapy, supportive care, and monitoring for infections. Prophylactic antibiotics may also be administered to prevent complications.
When should ICD-10 Code C81.39 be documented?
This code should be documented when a patient presents with lymphocyte depletion due to Hodgkin lymphoma, particularly when there is evidence of advanced disease or complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes